Validation of recent response criteria (ELN-22, IWG-23 and PB-CR) in 1634 MDS/CMML/AML patients treated with HMA or HMA-VEN using CPH models and a CPH deep neural network - Can or should response criteria be harmonized for similarly treated patients? Meeting Abstract


Authors: Pleyer, L.; Vaisband, M.; Klammer, P.; Drost, M.; Angermann, H.; Keil, F.; Petzer, V.; Heibl, S.; Moritz, J.; Girschikofsky, M.; Stampfl-Mattersberger, M.; Pichler, A.; Hartmann, B. L.; Aschauer, G.; Schmitt, C.; Vallet, S.; Boros, S.; Pichler, P.; Hammerl-Steiner, A.; Renneberg, F.; Majjiga, D.; Russ, G.; Egle, A.; Leisch, M.; Melchardt, T.; Zaborsky, N.; Faber, V.; Bewersdorf, J. P.; Zeidan, A. M.; Hasenauer, J.; Greil, R.
Abstract Title: Validation of recent response criteria (ELN-22, IWG-23 and PB-CR) in 1634 MDS/CMML/AML patients treated with HMA or HMA-VEN using CPH models and a CPH deep neural network - Can or should response criteria be harmonized for similarly treated patients?
Meeting Title: 66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 144
Issue: Suppl. 1
Meeting Dates: 2024 Dec 7-10
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2024-11-05
Start Page: 7511
Language: English
ACCESSION: WOS:001412631600026
DOI: 10.1182/blood-2024-208073
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors